EG18822A - Production and use of prophyrins - Google Patents

Production and use of prophyrins

Info

Publication number
EG18822A
EG18822A EG60989A EG60989A EG18822A EG 18822 A EG18822 A EG 18822A EG 60989 A EG60989 A EG 60989A EG 60989 A EG60989 A EG 60989A EG 18822 A EG18822 A EG 18822A
Authority
EG
Egypt
Prior art keywords
prophyrins
production
Prior art date
Application number
EG60989A
Other languages
English (en)
Inventor
Blaik P Halling
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Application granted granted Critical
Publication of EG18822A publication Critical patent/EG18822A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EG60989A 1988-12-12 1989-12-21 Production and use of prophyrins EG18822A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28515188A 1988-12-12 1988-12-12
US33500789A 1989-04-07 1989-04-07
US35133189A 1989-05-03 1989-05-03

Publications (1)

Publication Number Publication Date
EG18822A true EG18822A (en) 1994-09-29

Family

ID=27403508

Family Applications (1)

Application Number Title Priority Date Filing Date
EG60989A EG18822A (en) 1988-12-12 1989-12-21 Production and use of prophyrins

Country Status (28)

Country Link
EP (1) EP0447491B1 (xx)
JP (1) JP2545000B2 (xx)
KR (1) KR930003116B1 (xx)
AR (1) AR243605A1 (xx)
AT (1) AT400520B (xx)
AU (1) AU633537B2 (xx)
BR (1) BR8907817A (xx)
CA (1) CA2004979A1 (xx)
CH (1) CH681779A5 (xx)
DE (2) DE3991484C2 (xx)
DK (1) DK110791A (xx)
EG (1) EG18822A (xx)
ES (1) ES2051675T3 (xx)
FI (1) FI912784A0 (xx)
GB (1) GB2247404B (xx)
GR (1) GR1000609B (xx)
HU (1) HUT58202A (xx)
IE (1) IE62621B1 (xx)
IL (1) IL92622A (xx)
LU (1) LU87949A1 (xx)
LV (1) LV10303B (xx)
MC (1) MC2171A1 (xx)
NO (1) NO912228D0 (xx)
NZ (1) NZ231658A (xx)
OA (1) OA09362A (xx)
PT (1) PT92546B (xx)
SE (1) SE505938C2 (xx)
WO (1) WO1990006748A2 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298502A (en) * 1988-12-12 1994-03-29 Fmc Corporation Method and composition for photodynamic treatment and detection of tumors
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US6084155A (en) * 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
KR19990087356A (ko) * 1996-02-28 1999-12-27 더블류. 하링, 지. 보이롤 식물 프로토포르피리노겐 옥시다제 유전자로부터의 프로모터
JPH10330359A (ja) * 1997-03-31 1998-12-15 Nippon Bayeragrochem Kk フエニルアセチレン誘導体及び除草剤
DE102005017152B4 (de) * 2005-04-13 2007-02-08 Lindauer Dornier Gmbh Verfahren zum Trocknen von vorzugsweise plattenförmigen Produkten und Durchlauftrockner in Mehretagenbauweise
ES2417312T3 (es) 2009-06-19 2013-08-07 Basf Se Benzoxazinonas herbicidas
BR112012009987A2 (pt) * 2009-11-02 2015-09-29 Basf Se ''tetraidroftalimidas de fórmula ia ,processo para preparação de composições herbicidas ativas e método para controlar vegetações indesejadas''
US8669208B2 (en) 2010-10-01 2014-03-11 Basf Se Herbicidal benzoxazinones
CN103260412B (zh) 2010-12-15 2015-09-02 巴斯夫欧洲公司 除草组合物
CN102875569A (zh) * 2012-09-27 2013-01-16 南开大学 具有除草活性和抗肝癌活性的异噁唑并嘧啶酮(或三嗪酮)类化合物
WO2018108695A1 (en) * 2016-12-16 2018-06-21 Basf Se Herbicidal phenyltriazolinones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
US4404019A (en) * 1980-12-24 1983-09-13 Sumitomo Chemical Company, Limited 3-Chloro-1-phenyl-1,2,4-triazolin-5-ones and their use as herbicides
CH651029A5 (de) * 1980-12-25 1985-08-30 Nihon Nohyaku Co Ltd Triazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende herbizide mittel.
JPS60190711A (ja) * 1984-03-09 1985-09-28 Tokyo Tanabe Co Ltd プロトポルフイリン類注射用製剤
US4755217A (en) * 1987-01-15 1988-07-05 Fmc Corporation Triazinedione herbicides
US4761174A (en) * 1987-04-14 1988-08-02 Fmc Corporation Triazolin-5-one herbicides

Also Published As

Publication number Publication date
JP2545000B2 (ja) 1996-10-16
AU633537B2 (en) 1993-02-04
IL92622A (en) 1996-05-14
LU87949A1 (fr) 1991-12-16
SE9101807D0 (sv) 1991-06-12
WO1990006748A2 (en) 1990-06-28
KR910700046A (ko) 1991-03-13
CA2004979A1 (en) 1990-06-12
FI912784A0 (fi) 1991-06-10
OA09362A (en) 1992-09-15
GB2247404B (en) 1993-03-03
IE893925L (en) 1990-06-12
AU4822290A (en) 1990-07-10
JPH04501420A (ja) 1992-03-12
EP0447491A1 (en) 1991-09-25
DK110791A (da) 1991-08-12
GR890100817A (en) 1991-03-15
PT92546A (pt) 1990-06-29
WO1990006748A3 (en) 1990-10-04
CH681779A5 (xx) 1993-05-28
SE505938C2 (sv) 1997-10-27
EP0447491B1 (en) 1993-08-11
BR8907817A (pt) 1991-10-22
ES2051675T1 (es) 1994-07-01
DE3991484T (xx) 1991-11-21
DK110791D0 (da) 1991-06-11
PT92546B (pt) 1995-09-12
LV10303A (lv) 1994-10-20
NO912228L (no) 1991-06-11
NZ231658A (en) 1992-05-26
KR930003116B1 (ko) 1993-04-19
HUT58202A (en) 1992-02-28
GB9110472D0 (en) 1991-11-27
IE62621B1 (en) 1995-02-22
SE9101807L (sv) 1991-06-12
GR1000609B (el) 1992-08-31
AT400520B (de) 1996-01-25
LV10303B (en) 1995-08-20
AR243605A1 (es) 1993-08-31
ATA903489A (de) 1995-06-15
ES2051675T3 (es) 1994-11-01
DE3991484C2 (de) 1995-02-23
GB2247404A (en) 1992-03-04
NO912228D0 (no) 1991-06-11
IL92622A0 (en) 1990-08-31
MC2171A1 (fr) 1992-05-22

Similar Documents

Publication Publication Date Title
IL89885A0 (en) Fibrin-collagen tissue equivalents and their production
PT81859A (en) Thiazolidinedione derivatives their production and use
EG18822A (en) Production and use of prophyrins
GB2221396B (en) Catheters and methods of manufacture
PT84704A (en) Thiolactam-n-acetic derivatives their production and use
EP0420194A3 (en) Uracil derivatives and their production and use
US5036098B1 (en) Butynlamine derivatives and their production
GB2333292B (en) Derivatives of hexaazoisowurtzitane
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
AU8427091A (en) Gamma-carboxylase and methods of use
YU197489A (en) Production of human prourochinasis
ZA898741B (en) Use of azepinone derivatives
GB8802421D0 (en) Set of parts
JPS6450846A (en) Arylbisperfluoroalkylcarbinol and manufacture of same
IL92027A0 (en) Aryloxyaldehydes and their manufacture
MW1191A1 (en) Production and use of porphyrins
HK1003571A1 (en) Alkenyltetrazole derivatives their preparation and use
ZA897772B (en) Organotinfluorides and their manufacture
GB9013841D0 (en) Use of disamycin a and derivatives thereof
IE882090L (en) New use of 5-ht3-antagonists
YU62088A (en) Rolling of roll-cotton
CA60659S (en) Set of jewellery
IE900317L (en) Use of oxoquinazoline derivatives
ZA893970B (en) Methods of construction and implements therefor
GB8810369D0 (en) Improvements in use of solid-fuels